NDC 0006-3076 – Prevymis
Letermovir 480 mg/1 · Tablet, Film Coated · Oral
Product NDC0006-3076
Product details
- Brand name
- Prevymis
- Generic name
- Letermovir
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA209939
- Marketed since
- November 8, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Cytomegalovirus DNA Terminase Complex Inhibitor
Active ingredients
- Letermovir 480 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0006-3076-02 | 4 DOSE PACK in 1 CARTON (0006-3076-02) / 7 TABLET, FILM COATED in 1 DOSE PACK (0006-3076-01) | Nov 8, 2017 |
| 0006-3076-04 | 14 BLISTER PACK in 1 CARTON (0006-3076-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0006-3076-03) | Nov 8, 2017 |
Other Prevymis products
- 0006-3075 Letermovir 240 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC
- 0006-5003 Letermovir 20 mg/mL · Injection, Solution · Merck Sharp & Dohme LLC
- 0006-5004 Letermovir 20 mg/mL · Injection, Solution · Merck Sharp & Dohme LLC
- 0006-5085 Letermovir 120 mg/1 · Pellet · Merck Sharp & Dohme LLC
- 0006-5086 Letermovir 20 mg/1 · Pellet · Merck Sharp & Dohme LLC